Omega-3 Trial for Dementia Risk
- Coudl omega-3 fatty acids offer a cost-effective and well-tolerated treatment option for patients experiencing early dementia symptoms and those at risk of Alzheimer's...
- The World Health Organization (WHO) reports that over 55 million people worldwide are living with dementia, with nearly 10 million new cases diagnosed annually.
- Omega-3 long-chain polyunsaturated fatty acids (omega-3 PUFAs) play a vital role in human organ function, influencing inflammation, immunity, and hormone regulation.Thes fatty acids are also crucial for brain...
Omega-3 fatty Acids: A Potential Weapon Against Dementia and Alzheimer’s Disease
Table of Contents
- Omega-3 fatty Acids: A Potential Weapon Against Dementia and Alzheimer’s Disease
- Omega-3 Fatty Acids and Dementia: Can They help?
- Questions and Answers
- What is Dementia, and Why is it a Concern?
- What are Omega-3 Fatty Acids, and Why are They Critically important for Brain Health?
- How Can Omega-3 Fatty Acids Perhaps Help with Dementia and alzheimer’s Disease?
- What are Good Dietary Sources of Omega-3 Fatty Acids?
- What is the University of Cincinnati Clinical Trial Investigating?
- What is the Difference Between TAG-DHA and LPC-DHA?
- what are the Expected Outcomes of the University of Cincinnati clinical Trial?
- Summary Table: Omega-3 Fatty Acids and Dementia
- Where Can I Find More Details About Dementia and alzheimer’s Disease?
- Questions and Answers
Published:
Coudl omega-3 fatty acids offer a cost-effective and well-tolerated treatment option for patients experiencing early dementia symptoms and those at risk of Alzheimer’s disease? Researchers at the University of Cincinnati are exploring this possibility through a clinical trial. The trial compares two types of omega-3 supplements as potential interventions for older adults facing the risk of dementia.
The World Health Organization (WHO) reports that over 55 million people worldwide are living with dementia, with nearly 10 million new cases diagnosed annually. As of March 2023, dementia is the seventh leading cause of death globally and a major contributor to disability and dependency among older adults. Alzheimer’s disease, the most common form of dementia, accounts for approximately 60% to 70% of all cases.
the Importance of Omega-3 Fatty Acids
Omega-3 long-chain polyunsaturated fatty acids (omega-3 PUFAs) play a vital role in human organ function, influencing inflammation, immunity, and hormone regulation.Thes fatty acids are also crucial for brain advancement and function,serving as essential components of neuronal membranes. Since the human body cannot produce omega-3 PUFAs, they must be obtained through diet. The most prevalent omega-3 PUFAs are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Correcting age-related reductions in brain DHA levels represents a plausible strategy to slow or prevent neurodegenerative processes associated with dementia.
Robert McNamara, PhD, University of Cincinnati
According to Robert mcnamara, PhD, director of the Lipidomics Research Program and professor in the Department of Psychiatry and Behavioral Neuroscience at UC’s College of Medicine, “Correcting age-related reductions in brain DHA levels represents a plausible strategy to slow or prevent neurodegenerative processes associated with dementia.” He further notes,”Fish is a primary dietary source of lysophosphatidylcholine-bound DHA (LPC-DHA),and greater fish consumption by elderly adults has been shown to reduce the risk for developing dementia and AD by 30% to 50%.”
Dietary Sources of Omega-3
- Fatty fish: Mackerel, salmon, cod liver oil, herring, oysters, sardines, anchovies, and caviar
- Other foods: Flaxseed, chia seeds, walnuts, and soybeans
- Additional sources: Pasture-raised eggs, omega-3-enriched eggs, meats, and dairy products from grass-fed animals, hemp seeds, and certain vegetables
The University of Cincinnati Clinical Trial
While fish oil supplements offer a convenient alternative to consuming fish, they primarily contain triglyceride-bound DHA (TAG-DHA), which differs from the DHA found naturally in fish.
Recent evidence indicates that TAG-DHA has very limited entry into the central nervous system and instead accumulates in peripheral tissues, whereas LPC-DHA is substantially more effective for increasing brain DHA levels.
Robert McNamara, PhD, University of Cincinnati
McNamara explains that “Recent evidence indicates that TAG-DHA has very limited entry into the central nervous system and instead accumulates in peripheral tissues, whereas LPC-DHA is significantly more effective for increasing brain DHA levels.”
Previous clinical trials have explored the impact of omega-3 supplementation on dementia symptoms, but these studies were relatively small. The current trial at the University of Cincinnati stands out as the first of its kind, involving 153 adults aged 62 to 80 years with mild cognitive decline.
Study Design
Participants in the study will be randomly assigned to one of three groups for 24 weeks:
- Standard fish oil supplement with TAG-DHA
- New supplements with LPC-DHA
- Placebo
Participants are required to provide blood and cerebrospinal fluid (CSF) samples, along with undergoing a cognitive assessment at the beginning of the study and at week 25.
We predict that LPC-DHA supplementation will produce greater increases in CSF DHA levels compared with either TAG-DHA or placebo. We also predict that LPC-DHA will produce greater positive changes in neurodegenerative biomarker levels compared with TAG-DHA or placebo.
Robert McNamara, PhD, University of Cincinnati
McNamara stated, “We predict that LPC-DHA supplementation will produce greater increases in CSF DHA levels compared with either TAG-DHA or placebo. we also predict that LPC-DHA will produce greater positive changes in neurodegenerative biomarker levels compared with TAG-DHA or placebo.”
The study aims to determine how DHA levels in CSF correlate with both neurodegeneration and cognitive function. Researchers will measure DHA and neurodegenerative biomarkers in CSF samples and then assess whether changes in DHA levels are associated with improvements in planning, problem-solving, and memory.
collectively, these results are anticipated to provide novel proof-of-concept evidence in support of future LPC-DHA research in aging at-risk adults.
Robert McNamara, PhD, University of Cincinnati
“Collectively, these results are anticipated to provide novel proof-of-concept evidence in support of future LPC-DHA research in aging at-risk adults,” McNamara concluded.
Omega-3 Fatty Acids and Dementia: Can They help?
Could omega-3 fatty acids be a weapon against dementia and Alzheimer’s disease? Researchers are exploring this possibility, comparing different types of omega-3 supplements to see which might be most effective for older adults at risk. Learn more about the potential benefits of omega-3s, dietary sources, and exciting clinical trials.
Published: March 11, 2025
Questions and Answers
What is Dementia, and Why is it a Concern?
Dementia is a general term for a decline in mental ability severe enough to interfere with daily life.The World Health Organization (WHO) reports that dementia affects over 55 million people worldwide with nearly 10 million new cases diagnosed each year. As of March 2023, dementia is the seventh leading cause of death globally and a major contributor to disability and dependency among older adults. Alzheimer’s disease, the most common form of dementia, accounts for 60% to 70% of cases.
What are Omega-3 Fatty Acids, and Why are They Critically important for Brain Health?
Omega-3 long-chain polyunsaturated fatty acids (PUFAs) are vital for human organ function, influencing inflammation, immunity, and hormone regulation. They are also crucial for brain development and function, serving as essential components of neuronal membranes. Since the body cannot produce omega-3s, they must be obtained through diet. The most prevalent omega-3 PUFAs are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
How Can Omega-3 Fatty Acids Perhaps Help with Dementia and alzheimer’s Disease?
Research suggests that correcting age-related reductions in brain DHA levels could slow or prevent neurodegenerative processes associated with dementia. Robert McNamara,PhD,from the University of cincinnati,explains that fish is a primary dietary source of lysophosphatidylcholine-bound DHA (LPC-DHA) and that greater fish consumption by older adults has been shown to reduce the risk of developing dementia and Alzheimer’s disease by 30% to 50%.
What are Good Dietary Sources of Omega-3 Fatty Acids?
here are some excellent dietary sources of omega-3 fatty acids:
Fatty fish: Mackerel, salmon, cod liver oil, herring, oysters, sardines, anchovies, and caviar.
Other foods: Flaxseed, chia seeds, walnuts, and soybeans.
Additional sources: Pasture-raised eggs, omega-3-enriched eggs, meats and dairy products from grass-fed animals, hemp seeds, and certain vegetables.
What is the University of Cincinnati Clinical Trial Investigating?
The University of Cincinnati is conducting a clinical trial comparing two types of omega-3 supplements as potential interventions for older adults at risk of dementia. The trial involves 153 adults aged 62 to 80 years with mild cognitive decline. Participants are randomly assigned to one of three groups for 24 weeks:
- Standard fish oil supplement with triglyceride-bound DHA (TAG-DHA)
- New supplement with lysophosphatidylcholine-bound DHA (LPC-DHA)
- Placebo
The study aims to determine how DHA levels in cerebrospinal fluid (CSF) correlate with neurodegeneration and cognitive function.
What is the Difference Between TAG-DHA and LPC-DHA?
While fish oil supplements offer a convenient alternative to consuming fish, they primarily contain triglyceride-bound DHA (TAG-DHA), which differs from the DHA found naturally in fish. Recent evidence indicates that TAG-DHA has limited entry into the central nervous system and accumulates in peripheral tissues, whereas LPC-DHA is considerably more effective for increasing brain DHA levels.
what are the Expected Outcomes of the University of Cincinnati clinical Trial?
Researchers predict that LPC-DHA supplementation will produce greater increases in CSF DHA levels compared to TAG-DHA or placebo. They also anticipate that LPC-DHA will led to greater positive changes in neurodegenerative biomarker levels compared to TAG-DHA or placebo. Robert McNamara stated that the results are expected to provide novel proof-of-concept evidence in support of future LPC-DHA research in aging at-risk adults.
Summary Table: Omega-3 Fatty Acids and Dementia
| Feature | Description |
| ————————— | ————————————————————————————————————————————————————————————————————————————– |
| Dementia | A general term for a decline in mental ability severe enough to interfere with daily life. Affects over 55 million people worldwide. |
| Omega-3 Fatty Acids | Essential polyunsaturated fatty acids crucial for brain development, function, inflammation, immunity, and hormone regulation. |
| Types of Omega-3s | Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the most prevalent. |
| Dietary Sources | Fatty fish (mackerel, salmon), flaxseed, chia seeds, walnuts, soybeans, pasture-raised eggs, and grass-fed animal products. |
| TAG-DHA vs. LPC-DHA | TAG-DHA (triglyceride-bound) is commonly found in fish oil supplements but has limited entry to the brain. LPC-DHA (lysophosphatidylcholine-bound) is found naturally in fish and is more effective at increasing brain DHA levels. |
| UC Clinical Trial | Compares TAG-DHA, LPC-DHA, and placebo in older adults with mild cognitive decline. Aims to determine the impact on DHA levels in CSF, neurodegeneration, and cognitive function. |
| Expected Outcomes | LPC-DHA may lead to greater increases in CSF DHA and positive changes in neurodegenerative biomarkers. |
Where Can I Find More Details About Dementia and alzheimer’s Disease?
you can find more information on dementia and Alzheimer’s disease from the following sources:
World Health Organization (WHO)
* Alzheimer’s Society